Navigation Links
Intarcia Therapeutics Announces Presentation of Final Results From,a Phase 2 Combination Study for the Treatment of Hepatitis C at the,Digestive Disease Week Conference

ive patients in an open-label, multi-center, active-controlled study design. All study patients had genotype-1, the most treatment-resistant type of HCV, and the majority of patients (74%) had high baseline viral load (> 800,000 IU/ml), a well-established negative predictive factor for SVR. Patients received daily injections of omega interferon (25 mcg) for up to 48 weeks. The endpoints for this clinical trial were early viral response (EVR), defined as a 2-log reduction in HCV RNA after 12 weeks of treatment, and SVR, defined as undetectable HCV RNA 24 weeks after completion of 48 weeks of treatment. Response rates are presented in the table below:

    HCV RNA Results           Omega IFN + RBV        Omega IFN Alone

                                    N=67                   N=35

    Early Viral Response (EVR)      84 %                   60 %

    p= 0.014

    Sustained Viral Response

    (SVR) (LOD= 50 IU/ml)           36 %                    6 %

    p= 0.001


With this study, Intarcia also took a step toward testing its hypothesis that approximating continuous drug levels through daily administration of omega interferon may minimize side effects when compared to current interferon therapies. This study demonstrates that omega interferon is well tolerated with only two discontinuations due to adverse events. Results of this Phase 2 study suggest a favorable overall safety profile with no substantial safety issues being identified. Normalization of serum ALT, a marker of reduced liver inflammation, occurred in 100% of patients achieving SVR; and no patients receiving omega interferon with ribavirin experienced relapse during 24 weeks of follow-up after completing 48 weeks of treatment.

Alice Leung, President and Chief Executive Officer of Intarcia stated, "We are excited about the Phase 2 injectable omega interferon combination therapy results presented by Dr. Bacon at the DDW conference. Based on the data so far, we believe that a c
'"/>




Page: 1 2 3 4

Related medicine technology :

1. Intarcia Therapeutics Announces Final Results From a Phase 2 Study of Injectable Omega Interferon plus Ribavirin for the Treatment of Hepatitis C Genotype-1
2. Cell Therapeutics, Inc. Management to Discuss Todays Announcement of Interim Pixantrone Study Results
3. Halozyme Therapeutics Enhanze Technology Large Protein Molecule Therapeutic Clinical Trial Results Presented at the 34th Annual Meeting of the Controlled Release Society
4. CV Therapeutics Identifies Potential Anti-Diabetic Mechanism of Action for Ranexa
5. Fat Kills Cancer: Turning Stem Cells from Fat Tissue into Personalized, Cancer-Targeted Therapeutics
6. A 4-Week Therapy with Transition Therapeutics E1-I.N.T. Leads to Sustained Reductions in Blood Glucose Levels for 6 Months Post-treatment in Type 2 Diabetes Patients
7. Clinical Trial Suggests Bone Marrow Stem Cells Are Useful for Spinal Cord Injury; PrimeCell Therapeutics Provided Pre-Clinical Study
8. Opexa Therapeutics Reports Positive Top-line Data in Phase I/II Extension Trial with Tovaxin for Multiple Sclerosis
9. Orexigen Therapeutics to Present Data on Contrave Impact on Visceral Fat and Insulin Resistance at American Diabetes Association 67th Scientific Sessions in Chicago June 23
10. Allos Therapeutics Reports Results for Phase 3 Enrich Study of Efaproxyn in Women With Brain Metastases Originating From Breast Cancer
11. Trophos Publishes ALS Article in Journal of Pharmacology and Experimental Therapeutics
Post Your Comments:
(Date:8/22/2014)... 22, 2014  Medical Science Liaisons serve as a ... the healthcare sector. As the impact of technology in ... how Medical Science Liaisons (MSLs) interact with physicians and ... the tablet to not only share important disease and ... thought leader interactions across geographies and therapeutic areas. ...
(Date:8/22/2014)... 22, 2014 ... has announced the addition of the  "Global ... their offering.       (Logo: http://photos.prnewswire.com/prnh/20130307/600769) ... instrument for any modern science laboratory as ... materials. It can be broadly classified into ...
(Date:8/22/2014)... Research and Markets ( ... the  "Global Operating Room Equipment Market 2014-2018" ... (Logo: http://photos.prnewswire.com/prnh/20130307/600769) , ,An operating room is ... a healthcare facility used to perform surgical ... equipment, which ensures patient care and enhanced ...
Breaking Medicine Technology:iPads Enhancing Medical Science Liaison Interactions with Thought Leaders, New Study Shows 2Global Laboratory Electronic Balance Market 2014-2018: Key Vendors are A&D Company, Mettler-Toledo, Sartorius and Thermo Fisher 2Global Operating Room Equipment Market 2014-2018: Key Vendors are Getinge, STERIS, Stykron and TRUMPF Medical Systems 2
... June 13 Telmisartan, an angiotensin receptor blocker, ... been studied in clinical trials in more than 50,000 patients. ... market exposure of 34.5 million patient years. Convincing safety data ... the three long-term outcome trials ONTARGET, PRoFESS and TRANSCEND which ...
... Scientists from the Barbara Ann Karmanos Cancer Institute in ... agents used to promote bone health and inhibit resorption, may ... early stage breast cancer who take them for their anti-osteoporosis ... Society of Clinical Oncology Annual Meeting. , ...
Cached Medicine Technology:Boehringer Ingelheim Affirms Safety of Telmisartan With an Analysis of 50,000 Patients and Strongly Disagrees With the Publication of Sipahi et al in Lancet Oncology June 2010 2Boehringer Ingelheim Affirms Safety of Telmisartan With an Analysis of 50,000 Patients and Strongly Disagrees With the Publication of Sipahi et al in Lancet Oncology June 2010 3Boehringer Ingelheim Affirms Safety of Telmisartan With an Analysis of 50,000 Patients and Strongly Disagrees With the Publication of Sipahi et al in Lancet Oncology June 2010 4Boehringer Ingelheim Affirms Safety of Telmisartan With an Analysis of 50,000 Patients and Strongly Disagrees With the Publication of Sipahi et al in Lancet Oncology June 2010 5Karmanos Cancer Institute Researchers Study Bisphosphonates and Their Affect on Early Stage Breast Cancer 2Karmanos Cancer Institute Researchers Study Bisphosphonates and Their Affect on Early Stage Breast Cancer 3Karmanos Cancer Institute Researchers Study Bisphosphonates and Their Affect on Early Stage Breast Cancer 4
(Date:8/22/2014)... 2014 Today, Zane Benefits, the #1 ... Account-Based Health Plans. , According to Zane Benefits, employers ... to lower the cost of healthcare without reducing coverage ... accounts, however, can be confusing. , The new guide ... four main types of ABHPs. It also explains ...
(Date:8/22/2014)... Las Vegas, NV (PRWEB) August 22, 2014 ... affordable email marketing services that currently helps more ... marketing efforts has caught the attention of Shane Michaels, ... a still a crucial element for any online marketing ... media replacing email in the marketing world,” reports Michaels. ...
(Date:8/22/2014)... 2014 Top 10 Best SEO ... hosting companies and highly recommended FatCow ( http://www.top10bestseohosting.com/go/FatCow.com/ ... manager of Top 10 Best SEO Hosting states, ... server hosting supplier. Actually, these companies have outperformed ... and customer support. People can get the best ...
(Date:8/22/2014)... NV (PRWEB) August 22, 2014 ... that is written by marketing experts for marketers to ... links has caught the attention of Shane Michaels, prompting ... with Internet marketing in any way knows that content ... in the industry,” reports Michaels. “But even though content ...
(Date:8/22/2014)... (PRWEB) August 23, 2014 Recently, UWDress.com, a ... outfits, has added a new range of empire bridesmaid ... the company has launched a summer promotion for these high ... discounted rates, from 25 to 75 percent off. , ... ladies. Also, UWDress.com offers efficient assistance on its website. It ...
Breaking Medicine News(10 mins):Health News:AWeber: Review Exposes Affordable Provider of Opt-In Email Marketing Services 2Health News:FatCow Reviews Released by Top10BestSEOHosting.com 2Health News:My Writers: Review Exposes Online Source for Quality Marketing Content 2Health News:Discounted Empire Bridesmaid Dresses Online At UWDress.com 2
... is widespread disgust and outrage expressed over the housing together ... Sebastian Wheeler, 43, and his boyfriend Victor Leslie Urquhart, ... Australia. ,The two men were convicted ... him for 20 days, before he was rescued. The pair ...
... tuberculosis, researchers say. ,A study of 131 people found ... to inhibit the growth of the bacteria causing the disease, reported ... has evaluated the effect of Vitamin D on the body's immunity ... researchers took blood from all the participants and infected with mycobacteria. ...
... Low-income African-American high school students with asthma who ... reported fewer days and nights with symptoms, ... activity, and less hospitalization for asthma during a ... students. ,Christine L. M. Joseph, M.P.H, ...
... At least eight people have died due to sunstroke in ... ,While three deaths have been reported from the ... from the districts of Balasore, Kandhamal, Kendrapada, Nuapada and Sundergarh, ... told IANS. ,We received complaints of about 53 ...
... not that killer body that the opposite sex takes into account ... if you are a man. ,To find our ... from the University of Western Australia in Crawley led by Marianne ... photographs. ,The volunteers were asked to rate attractiveness on ...
... that Alzheimers drug Donepezil may help people who have ... Berthier of the M dico-Sanitarias Research Centre in Malaga, ... ability to communicate. ,The researchers wanted to ... a condition characterised by an inability to pronounce or ...
Cached Medicine News:Health News:Outrage Against Gay PartnersInCrime Kept Together 2Health News:Web-based Asthma Program Improves Disease Management for Black Students 2
... Crossover system of implants and instruments provides ... posterior rod construct in the thoracic and ... system are available in three size ranges: ... can be used with the Isola, Pediatric ...
Portable ultrasound doppler system for peripheral and transcranial investigation....
Multiwindow transcranial and peripheral Doppler system....
Bi-Directional doppler volume flowmeter....
Medicine Products: